

What we know (and don't know) about the new Mpox outbreak
Aug 29, 2024
Dr. Jonas Albarnaz, a pox virus expert from The Pirbright Institute, joins Dr. Lilith Whittles, a lecturer focused on infectious disease analysis, Dr. Josie Golding, head of epidemiology at The Wellcome Trust, and Trudie Lang, a global health professor. They dive into the emerging Mpox outbreak, discussing its origins, symptoms, and the challenges of viral mutation. The group highlights the urgent need for research on vaccine distribution and the implications of evolving transmission dynamics as they navigate global health preparedness.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
Understanding M-POCS Virus Dynamics
02:29 • 4min
Understanding Mpox: Symptoms, Strains, and Implications
06:09 • 2min
Understanding Mpox Clades: 1A vs. 1B
08:00 • 10min
Navigating Viral Mutations and Vaccine Challenges
17:58 • 11min
Importance of Vaccine Distribution in Mpox Response
28:29 • 2min